Enlight medical is developing transcatheter mitral valve repair and replacement devices.
Enlight Medical is selling thoracic endovascular stent graft to treat aortic dissection, and developing innovative peripheral stents to treat PAD.
Enlight Medical is developing deep brain stimulation (DBS) and spinal cord stimulation (SCS) devices.
Enlight Medical is developing invasive and non-invasive BCIs to help replace, restore, or improve human functions.
Enlight Medical has partnered with Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, to accelerates commercial availability of Seer’s Proteograph Product Suite to the rapidly expanding Chinese life sciences and clinical markets.
@Copyright 2020-2022 Enlight Medical Limited All rights reserved 沪ICP备20012889号-2